Dublin, Aug. 25, 2020 (GLOBE NEWSWIRE) -- The "Brain Aneurysm Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; Condition; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.
The brain aneurysm treatment market was valued at US$ 2,184.15 million in 2019 and is expected to grow at a CAGR of 14.1% from 2020 to 2027 to reach US$ 6,222.47 million by 2027.
Driving factors of the brain aneurysm treatment market are increasing prevalence of brain aneurysm and associated risk factors and rise in research and development activities. However, high cost of surgical proceduresis likely to have negative impact on the growth of the market during the forecast period.
Brain aneurysm is a development of bulge in the blood vessels of brain. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which may lead to the death of patient. Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The growth of brain aneurysm treatment market is prominently attributed to the increasing prevalence of brain aneurysm across the globe. Additionally, increasing number of diagnostic procedures associated with the brain are also expected to implicitly accelerate the growth of the market during the forecast period. According to a data published by the Brain Aneurysm Foundation in 2020, an estimated 6.5 million people in the US are suffering from unruptured brain aneurysm, which accounts for around 1 in 50 people. Additionally, an estimated 500,000 deaths are caused due to brain aneurysms across the globe each year.
Increasing number of associated risk factors to cause brain aneurysm is also anticipated to drive the prevalence of the disease, which will eventually boost the growth of brain aneurysm treatment market during the forecast period. For instance, according to the data published by Centers of Disease Control and Prevention (CDC) in 2018, an estimated 14 out of 100 people in the US smoke cigarettes. Along with smoking and tobacco consumption, hypertension is also one of the prominent factors, which is raising the prevalence of brain aneurysm among the population. According to World Health Organization (WHO) in 2019, an estimated 1.13 billion population was suffering from hypertension across the globe. Such massive epidemics of hypertension are likely to increase the cases of brain aneurysm, which in turn will propel the growth of brain aneurysm treatment market from 2020-2027.
The global brain aneurysm treatment market is segmented by type, condition, and end user. The brain aneurysm treatment market, by type, is segmented into medication and surgery. The medication segment held the largest share of the market. However, surgery segment is expected to register the highest CAGR in the market during the forecast period. Based on condition, the brain aneurysm treatment market is segmented into unruptured aneurysm and ruptured aneurysm. The unruptured aneurysm held the largest share of condition segment in the global market. However, ruptured aneurysm segment is expected to grow at the faster rate during the forecast period.
Based on end user, the brain aneurysm treatment market is segmented into hospitals and clinics. The hospitals held the largest share of the brain aneurysm treatment market for the end user segment. However, the clinics segment is expected to grow at the fastest rate during the coming years.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the brain aneurysm treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global brain aneurysm treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Key Topics Covered:
2. Brain Aneurysm Treatment Market - Key Takeaways
3. Research Methodology
3.2 Secondary Research
3.3 Primary Research
4. Global Brain Aneurysm Treatment Market - Market Landscape
4.1 Pest Analysis
4.1.1 North America- PEST Analysis
4.1.2 Europe- PEST Analysis
4.1.3 Asia Pacific- PEST Analysis
4.1.4 Middle East and Africa- PEST Analysis
4.1.5 South and Central America- PEST Analysis
5. Global Brain Aneurysm Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Brain Aneurysm and Associated Risk Factors
5.1.2 Rise in Research and Development Activities
5.2 Market Restraints
5.2.1 High Cost of Surgical Procedures
5.3 Market Opportunities
5.3.1 Increasing Financial Aid to Boost the Innovation
5.4 Future Trends
5.4.1 Adoption of Surgical Robots for the Treatment of Brain Aneurysm
5.5 Impact analysis
6. Brain Aneurysm Treatment Market- Global Analysis
6.1 Global Brain Aneurysm Treatment Market Revenue Forecast And Analysis
6.2 Global Brain aneurysm treatment Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Brain Aneurysm Treatment Market Analysis - By Type
7.2 Brain Aneurysm Treatment Market Share, by Type, 2019 and 2027 (%)
7.3.2 Surgery: Brain Aneurysm Treatment Market- Revenue and Forecast to 2027 (US$ million)
7.4.2 Medication: Brain Aneurysm Treatment Market- Revenue and Forecast to 2027 (US$ million)
8. Brain aneurysm treatment Market Analysis - By Condition
8.2 Brain Aneurysm Treatment Market Share, by Condition, 2019 and 2027, (%)
8.3 Unruptured Aneurysm
8.3.2 Unruptured Aneurysm: Brain Aneurysm Treatment Market - Revenue and Forecast to 2027 (US$ million)
8.4 Ruptured Aneurysm
8.4.2 Ruptured Aneurysm: Brain Aneurysm Treatment Market - Revenue and Forecast to 2027 (US$ million)
9. Brain aneurysm treatment Market Analysis - By End User
9.2 Brain Aneurysm Treatment Market Share, by End User, 2019 and 2027, (%)
9.3.2 Hospitals: Brain Aneurysm Treatment Market - Revenue and Forecast to 2027 (US$ million)
9.4.2 Clinics: Brain Aneurysm Treatment Market - Revenue and Forecast to 2027 (US$ million)
10. Brain Aneurysm Treatment Market - Geographic Analysis
10.1 North America: Brain Aneurysm Treatment Market
10.2 Europe: Brain Aneurysm Treatment Market
10.3 Asia Pacific: Brain Aneurysm Treatment Market
10.4 MEA: Brain Aneurysm Treatment Market
10.5 South & Central America: Brain Aneurysm Treatment Market
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BRAIN ANEURYSM TREATMENT MARKET
11.1 North America: Impact assessment of COVID-19 Pandemic
11.2 Europe: Impact assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
11.4 Rest of World: Impact assessment of COVID-19 Pandemic
12. Brain Aneurysm Treatment Market - Industry Landscape
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.4 Inorganic Developments
13. COMPANY PROFILES
13.1 Stryker Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MicroPort Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Terumo Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Penumbra, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Johnson & Johnson Services, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 KANEKA CORPORATION
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Mizuho Medical Co, Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Adeor medical AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Evasc Medical Systems Corp.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14.1 About the Publisher
14.2 Glossary of Terms
For more information about this report visit https://www.researchandmarkets.com/r/uy8c4
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900